A detailed history of Douglas Lane & Associates, LLC transactions in Stryker Corp stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 1,214 shares of SYK stock, worth $450,163. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,214
Previous 864 40.51%
Holding current value
$450,163
Previous $293,000 49.49%
% of portfolio
0.01%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$315.94 - $371.96 $110,579 - $130,186
350 Added 40.51%
1,214 $438,000
Q2 2024

Jul 08, 2024

BUY
$324.3 - $354.67 $94,695 - $103,563
292 Added 51.05%
864 $293,000
Q1 2024

Apr 11, 2024

SELL
$293.94 - $358.71 $333,621 - $407,135
-1,135 Reduced 66.49%
572 $204,000
Q4 2023

Jan 17, 2024

SELL
$253.85 - $299.46 $45,185 - $53,303
-178 Reduced 9.44%
1,707 $511,000
Q3 2023

Oct 16, 2023

BUY
$266.54 - $302.43 $19,723 - $22,379
74 Added 4.09%
1,885 $515,000
Q2 2023

Jul 19, 2023

SELL
$271.49 - $305.09 $48,868 - $54,916
-180 Reduced 9.04%
1,811 $552,000
Q1 2023

Apr 17, 2023

SELL
$246.13 - $285.47 $31,996 - $37,111
-130 Reduced 6.13%
1,991 $568,000
Q4 2022

Jan 17, 2023

SELL
$205.51 - $253.93 $5,959 - $7,363
-29 Reduced 1.35%
2,121 $519,000
Q3 2022

Oct 14, 2022

BUY
$189.27 - $231.83 $3,785 - $4,636
20 Added 0.94%
2,150 $435,000
Q1 2022

Apr 25, 2022

SELL
$245.33 - $277.77 $4,906 - $5,555
-20 Reduced 0.93%
2,130 $569,000
Q4 2021

Jan 25, 2022

BUY
$236.63 - $276.44 $23,189 - $27,091
98 Added 4.78%
2,150 $575,000
Q3 2021

Oct 21, 2021

BUY
$248.9 - $280.09 $8,462 - $9,523
34 Added 1.68%
2,052 $541,000
Q1 2021

Apr 19, 2021

BUY
$221.01 - $248.82 $1,326 - $1,492
6 Added 0.3%
2,018 $492,000
Q4 2020

Jan 14, 2021

SELL
$202.01 - $245.04 $13,130 - $15,927
-65 Reduced 3.13%
2,012 $493,000
Q2 2020

Jul 28, 2020

BUY
$144.67 - $207.03 $23,870 - $34,159
165 Added 8.63%
2,077 $374,000
Q1 2020

Apr 20, 2020

SELL
$126.5 - $225.1 $6,072 - $10,804
-48 Reduced 2.45%
1,912 $318,000
Q4 2019

Jan 27, 2020

BUY
$197.98 - $220.53 $43,555 - $48,516
220 Added 12.64%
1,960 $411,000
Q3 2019

Oct 16, 2019

SELL
$205.4 - $221.82 $10,270 - $11,091
-50 Reduced 2.79%
1,740 $376,000
Q1 2019

Apr 23, 2019

SELL
$152.46 - $198.0 $6,250 - $8,118
-41 Reduced 2.24%
1,790 $354,000
Q4 2018

Jan 17, 2019

BUY
$145.0 - $178.65 $14,500 - $17,865
100 Added 5.78%
1,831 $287,000
Q3 2018

Oct 09, 2018

BUY
$163.25 - $177.68 $18,120 - $19,722
111 Added 6.85%
1,731 $308,000
Q2 2018

Jul 23, 2018

SELL
$155.17 - $179.78 $23,275 - $26,967
-150 Reduced 8.47%
1,620 $274,000
Q1 2018

Apr 23, 2018

SELL
$148.01 - $168.91 $14,801 - $16,891
-100 Reduced 5.35%
1,770 $285,000
Q4 2017

Jan 24, 2018

BUY
$143.51 - $159.74 $4,305 - $4,792
30 Added 1.63%
1,870 $290,000
Q3 2017

Oct 19, 2017

BUY
$138.36 - $147.87 $254,582 - $272,080
1,840
1,840 $261,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $140B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.